• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FIB-4 指数和肝纤维化是与房颤相关卒中患者长期预后的危险因素。

FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related stroke.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, South Korea.

Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea; Zebrafish Translational Medical Research Center, Korea University Ansan Hospital, Ansan, South Korea.

出版信息

Clin Neurol Neurosurg. 2022 Jun;217:107235. doi: 10.1016/j.clineuro.2022.107235. Epub 2022 Apr 4.

DOI:10.1016/j.clineuro.2022.107235
PMID:35429852
Abstract

OBJECTIVE

Liver fibrosis (LF) is associated with a poor prognosis in patients with ischemic stroke (IS). We aimed to assess whether LF affects long-term outcomes in patients with atrial fibrillation-related stroke or such effects vary according to sex.

METHODS

We conducted a multicenter prospective cohort study of Korean patients with atrial fibrillation-related IS. We calculated the fibrosis-4 (FIB-4) index, and LF degree was categorized into two groups (non-advanced vs. advanced) based on the FIB-4 index. Recurrent IS, major adverse cardiac events (MACEs), and all-cause mortality were evaluated using Cox proportional hazard model.

RESULTS

A total of 2897 patients were included; the median age was 75 (interquartile range 68-80) years, and 51.8% were men. The median follow-up period was 16.3 months. Of these patients, 23% had advanced LF indicated by FIB-4 index. Multivariable analysis in all populations demonstrated that the FIB-4 index and advanced LF were significantly associated with MACEs and all-cause mortality but not with recurrent IS. Furthermore, a sex disparity was observed in the outcomes of the patients. A high FIB-4 index in men was a significant predictor of recurrent IS [subdistribution hazard ratio (95% confidence interval): 1.08 (1.02-1.14)]. However, the significance of advanced LF disappeared in MACEs in women and in all-cause mortality in men.

CONCLUSION

The FIB-4 index and advanced LF indicated by FIB-4 index are independent prognostic factors for long-term outcomes in Asian patients with atrial fibrillation-related IS. However, these predictors may contribute differently to patient outcomes depending on the sex.

摘要

目的

肝纤维化(LF)与缺血性脑卒中(IS)患者的预后不良相关。我们旨在评估 LF 是否影响房颤相关性脑卒中患者的长期预后,以及这种影响是否因性别而异。

方法

我们进行了一项多中心前瞻性队列研究,纳入了韩国房颤相关性 IS 患者。我们计算了纤维化-4 (FIB-4)指数,并根据 FIB-4 指数将 LF 程度分为两组(非进展性 vs. 进展性)。使用 Cox 比例风险模型评估复发性 IS、主要不良心脏事件(MACEs)和全因死亡率。

结果

共纳入 2897 例患者,中位年龄为 75 岁(四分位距 68-80 岁),51.8%为男性。中位随访时间为 16.3 个月。其中,23%的患者 FIB-4 指数提示存在进展性 LF。多变量分析显示,FIB-4 指数和进展性 LF 与 MACEs 和全因死亡率显著相关,但与复发性 IS 无关。此外,患者的结局存在性别差异。男性中较高的 FIB-4 指数是复发性 IS 的显著预测因素[亚分布危险比(95%置信区间):1.08(1.02-1.14)]。然而,在女性中,进展性 LF 在 MACEs 中的意义消失,在男性中,FIB-4 指数在全因死亡率中的意义消失。

结论

FIB-4 指数和 FIB-4 指数提示的进展性 LF 是亚洲房颤相关性 IS 患者长期预后的独立预测因素。然而,这些预测因素可能因性别而异,对患者结局的贡献也不同。

相似文献

1
FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related stroke.FIB-4 指数和肝纤维化是与房颤相关卒中患者长期预后的危险因素。
Clin Neurol Neurosurg. 2022 Jun;217:107235. doi: 10.1016/j.clineuro.2022.107235. Epub 2022 Apr 4.
2
Fibrosis-4 index is closely associated with clinical outcomes in acute cardioembolic stroke patients with nonvalvular atrial fibrillation.纤维 4 指数与非瓣膜性心房颤动急性心源性脑栓塞患者的临床结局密切相关。
Intern Emerg Med. 2023 Nov;18(8):2209-2222. doi: 10.1007/s11739-023-03394-6. Epub 2023 Oct 27.
3
Liver Fibrosis-4 index indicates atrial fibrillation in acute ischemic stroke.肝纤维化-4 指数可预测急性缺血性脑卒中患者的心房颤动。
Eur J Neurol. 2022 Aug;29(8):2283-2288. doi: 10.1111/ene.15377. Epub 2022 May 24.
4
Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index.肝纤维化与心房颤动结局:FIB-4 指数。
Clin Res Cardiol. 2024 Feb;113(2):313-323. doi: 10.1007/s00392-023-02330-0. Epub 2023 Nov 27.
5
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack.首次缺血性卒中和短暂性脑缺血发作患者中,肝纤维化程度高预示着不良的长期预后。
Cerebrovasc Dis. 2020;49(5):474-480. doi: 10.1159/000510436. Epub 2020 Sep 25.
6
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.维生素 K 或非维生素 K 拮抗剂口服抗凝剂治疗伴晚期肝纤维化的心房颤动患者的出血发生率。
Int J Cardiol. 2018 Aug 1;264:58-63. doi: 10.1016/j.ijcard.2018.01.097.
7
Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.左心房大小与非瓣膜性心房颤动急性缺血性脑卒中后复发性脑卒中的长期风险。
J Am Heart Assoc. 2017 Aug 15;6(8):e006402. doi: 10.1161/JAHA.117.006402.
8
Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.肝纤维化评估:无丙型和乙型肝炎感染的 HIV 感染患者队列中,非侵入性评分(APRI 和 FIB-4)演变及其预测因子的一致性分析。
Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.
9
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population.纤维化-4指数可预测成年韩国人群的长期全因死亡率、心血管死亡率和肝脏相关死亡率。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3322-3335. doi: 10.1016/j.cgh.2023.04.026. Epub 2023 May 8.
10
Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke.大血管闭塞性卒中中肝纤维化的无创标志物及预后
Ther Adv Neurol Disord. 2021 Aug 31;14:17562864211037239. doi: 10.1177/17562864211037239. eCollection 2021.

引用本文的文献

1
Impact of non-alcoholic fatty liver disease and liver fibrosis on outcomes of acute ischemic stroke: A systematic review and meta-analysis.非酒精性脂肪性肝病和肝纤维化对急性缺血性卒中预后的影响:一项系统评价和荟萃分析。
Pak J Med Sci. 2025 Feb;41(2):630-636. doi: 10.12669/pjms.41.2.10729.